The present study was aimed at evaluating possible relationship between the p16INK4A and p14ARF expression on the one hand, and both clinical and pathological features of thyroid carcinomas on the other hand, by using quantitative RT–PCR and immunohistochemistry approaches. The gene discussed is CDKN2A; the disease is thyroid gland carcinoma.